MetLife Inc., US59156R1086

MetLife stock gained 2.59 percent as Q2 EPS rose 20 percent

Published on 10/05/2026 at 22:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

MetLife stock drew a USD 110.00 TD Cowen target after the analyst lifted it from USD 105.00 on October 5, 2026. Q2 net income reached USD 705 million.

Trading-Floor mit großen Bildschirmen und abstrakten Finanzcharts in Grün und Rot
Editorial-Aufnahme eines Börsenparketts mit Aktiencharts, relevant für MetLife Inc., ISIN US59156R1086, NYSE gelistet, Illustration mit AI erstellt.

MetLife stock (ISIN US59156R1086) gained 2.59 percent to USD 96.88 on the NYSE on October 5, 2026, at 4:00 p.m. ET. The move followed a fresh TD Cowen target increase, while the insurer's latest quarter showed adjusted earnings per share up 20 percent to USD 2.43.

Q2 earnings show stronger adjusted profit

According to StockTitan in its August 5, 2026 8-K summary, MetLife reported USD 705 million in second-quarter net income, or USD 1.09 per share. Adjusted earnings increased 15 percent to USD 1.6 billion, and adjusted EPS rose 20 percent to USD 2.43 for Q2 2026.

The earnings mix matters because the adjusted figure advanced faster than GAAP net income. MetLife also reported premiums, fees and other revenues of USD 13.7 billion, up 7 percent in Q2 2026, while net investment income increased 18 percent to USD 6.7 billion, according to StockTitan.

TD Cowen lifts target to USD 110

TD Cowen maintained a Buy rating and raised its MetLife target from USD 105.00 to USD 110.00 on October 5, 2026, according to MarketBeat. The new target lies 13.54 percent above the USD 96.88 price, using the same-day NYSE quotation.

MarketBeat also reports a Buy consensus from 12 analysts and an average price target of USD 104.69. That consensus target lies 8.06 percent above the October 5, 2026 price, giving the current analyst view a wider cushion than the single-day market move.

Stock remains below its yearly high

MetLife's October 5, 2026 NYSE range ran from USD 94.66 to USD 97.39, with volume of 4,325,814 shares. The stock's 52-week range was USD 67.33 to USD 100.93, placing the latest price 4.01 percent below the high.

Market capitalization stood at USD 62.3 billion on October 5, 2026. The combination of double-digit adjusted EPS growth, a USD 3.0 billion repurchase authorization approved with the Q2 results, and higher analyst targets gives the stock a clearly quantified earnings and capital-return backdrop.

MetLife stock closes in on the yearly high

MetLife stock was last at USD 96.88 on the NYSE on October 5, 2026 at 4:00 p.m. ET, up 2.59 percent from the prior close of USD 94.43.

MetLife stock details

  • Company: MetLife, Inc.
  • ISIN: US59156R1086
  • Ticker: MET
  • Trading venue: NYSE
  • Price (as of October 5, 2026, 4:00 p.m. ET): USD 96.88
  • Market capitalization: USD 62.3 billion (as of October 5, 2026)
  • 52-week range: USD 67.33-100.93 (as of October 5, 2026)
  • Sector / Industry: Financial Services / Insurance

More news and analyses on MetLife stock

Disclaimer...

en | US59156R1086 | METLIFE INC. | boerse | 70237348 | bgmi